Gil Amarilyo
Impact in
- Hematology top 5%
- Autoimmune and Inflammatory Disorders Research
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
Papers in
- Hematology 26
- Autoimmune and Inflammatory Disorders Research 23
-
- Adolescent and Pediatric Healthcare 6
- Co-authors
- Antonio La CavaFu‐Dong ShiLiora HarelFrancis B. MimouniElaine LourençoAsaf OrenDror MandelV Deutsch
- Journals
- Seminars in Arthritis and Rheumatism (7 papers)Pediatric Rheumatology (7 papers)Annals of the Rheumatic Diseases (6 papers)The Journal of Pediatrics (4 papers)Lara D. Veeken (4 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Gil Amarilyo
68 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 102
- Hematology 198
- Immunology 365
- Rheumatology 211
- Speech and Hearing 54
- Obstetrics and Gynecology 58
Countries citing papers authored by Gil Amarilyo
This map shows the geographic impact of Gil Amarilyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gil Amarilyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gil Amarilyo more than expected).
Fields of papers citing papers by Gil Amarilyo
This network shows the impact of papers produced by Gil Amarilyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gil Amarilyo. The network helps show where Gil Amarilyo may publish in the future.
Co-authors
The 25 scholars most cited alongside Gil Amarilyo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 0 | |
| 12 | 2021 | 4 | |
| 13 | 2020 | 50 | |
| 14 | 2020 | 14 | |
| 15 | 2019 | 6 | |
| 16 | 2019 | 3 | |
| 17 | 2018 | 7 | |
| 18 | 2018 | 26 | |
| 19 | High-dose aspirin for Kawasaki disease: outdated myth or effective aid? | 2017 | 22 |
| 20 | 2012 | 14 |
About Gil Amarilyo
Gil Amarilyo is a scholar working on Hematology, Speech and Hearing, Rheumatology, Immunology and Ophthalmology, having authored 73 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammasome and immune disorders (25 papers), Autoimmune and Inflammatory Disorders Research (23 papers), Streptococcal Infections and Treatments (8 papers), Systemic Lupus Erythematosus Research (7 papers), Adolescent and Pediatric Healthcare (6 papers), Kawasaki Disease and Coronary Complications (6 papers), Ocular Diseases and Behçet’s Syndrome (5 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Hematology (198 citations), Immunology (365 citations), Rheumatology (211 citations), Speech and Hearing (54 citations) and Obstetrics and Gynecology (58 citations). Gil Amarilyo has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Antonio La Cava, Fu‐Dong Shi, Liora Harel, Francis B. Mimouni, Elaine Lourenço, Asaf Oren, Dror Mandel, V Deutsch, Yifat Ochshorn and Ivan Foeldvari. Their work appears in journals such as Seminars in Arthritis and Rheumatism, Pediatric Rheumatology, Annals of the Rheumatic Diseases, The Journal of Pediatrics and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.